AK

Arun Kumar Tiwari

Active Director Additional Director DIN 09499685
DIN 09499685 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Arun Kumar Tiwari

Data last updated:

Arun Kumar Tiwari is an Additional Director at Sumyansh Health Care Private Limited (since 2022). The company operates in Chemicals.

DIN 09499685
Primary Designation Additional Director
Industry Chemicals
First Appointment 09 Feb 2022
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sumyansh Health Care Private Limited U24233UP2015PTC071041
Additional Director09 Feb 20222015Active

Board colleagues of Arun Kumar Tiwari

Directorship timeline

Open interactive timeline →
Sumyansh Health Care Private Limited
Premium access

Shareholding and investment profile for Arun Kumar Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Kumar Tiwari

Arun Kumar Tiwari currently holds 1 directorship: Sumyansh Health Care Private Limited (Additional Director, since 09 Feb 2022).

Arun Kumar Tiwari was first appointed on 09 Feb 2022 as Additional Director at Sumyansh Health Care Private Limited.

The current boards of Arun Kumar Tiwari's companies include Bhuvnesh Tomar (Sumyansh Health Care Private Limited), Sumit Kumar Bansal (Sumyansh Health Care Private Limited), Urmila Tiwari (Sumyansh Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available